Stryker (SYK) Stock Price, News & Analysis

Company Overview

Stryker Corporation, headquartered in Kalamazoo, Michigan, is a leading global medical technologies company founded in 1941 by Dr. Homer Stryker. Initially known for its innovative hospital bed and mobile frame for medical equipment, the company has grown to serve a broad range of healthcare providers with products and services designed to enhance patient care and operational efficiency.

Stryker operates through three core segments: Orthopedics, MedSurg, and Neurotechnology & Spine. The Orthopedics division focuses on joint replacement, trauma and extremities, and bone cement, delivering implants for hip, knee, shoulder, and extremity reconstruction. The MedSurg segment supplies surgical equipment, endoscopy systems, and communications solutions, while the Neurotechnology & Spine branch offers products for neurological and spinal surgery, including implants, navigation technologies, and surgical instruments.

The company is renowned for its portfolio of advanced medical devices, including robotic surgical systems such as the Mako platform for joint replacement, high-definition endoscopic towers, and hospital infrastructure products like stretchers, beds, and emergency medical equipment. Stryker’s commitment to research and development has led to continual innovation, visible in its minimally invasive surgical tools and digital health solutions that support data-driven clinical decision-making.

With operations in over 100 countries and a workforce spanning multiple continents, Stryker maintains a strong presence across North America, Europe, Asia, and emerging markets. Under the leadership of Chairman and CEO Kevin Lobo, the company continues to expand its global footprint through strategic acquisitions and partnerships, reinforcing its position as a cornerstone in the healthcare industry.

Key Stats

• Today's Range: $387.14 to $392.79
• 50-Day Range: $373.22 to $396.38
• 52-Week Range: $314.93 to $406.19
• Volume: 871,885 shs
• Average Volume: 1.35 million shs
• Market Capitalization: $149.64 billion
• P/E Ratio: 52.98
• Dividend Yield: 0.86%
• Price Target: $428.55
• Consensus Rating: Moderate Buy

Stryker Stock Analysis - MarketRank™

Stryker scored higher than 93% of companies evaluated by MarketBeat, and ranked 79th out of 921 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Stryker has received a consensus rating of Moderate Buy. The company's average rating score is 2.79, and is based on 15 buy ratings, 4 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Stryker has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: 10.10%

Earnings Growth

Earnings for Stryker are expected to grow by 10.10% in the coming year, from $13.47 to $14.83 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Stryker is 52.98, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.16.

Price to Earnings Ratio vs. Sector

The P/E ratio of Stryker is 52.98, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 19.90.

Price to Earnings Growth Ratio

Stryker has a PEG Ratio of 2.94. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Stryker has a P/B Ratio of 7.24. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.43% of the float of Stryker has been sold short.

Short Interest Ratio / Days to Cover

Stryker has a short interest ratio ("days to cover") of 3.4, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Stryker has recently increased by 2.61%, indicating that investor sentiment is decreasing.

Dividend

• Score: 3.3 / 5
• Dividend Strength: Strong

Dividend Yield

Stryker has a dividend yield of 0.86%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

Stryker has been increasing its dividend for 32 years.

Dividend Coverage

The dividend payout ratio of Stryker is 45.41%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Stryker will have a dividend payout ratio of 22.66% next year. This indicates that Stryker will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: 4.2 / 5
• Environmental Score: -0.95

Percentage of Shares Shorted

1.43% of the float of Stryker has been sold short.

Short Interest Ratio / Days to Cover

Stryker has a short interest ratio ("days to cover") of 3.4, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Stryker has recently increased by 2.61%, indicating that investor sentiment is decreasing.

News and Social Media

• Score: 3.6 / 5
• News Sentiment: 1.44

News Sentiment

Stryker has a news sentiment score of 1.44. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.57 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 42 news articles for Stryker this week, compared to 29 articles on an average week.

Search Interest

7 people have searched for SYK on MarketBeat in the last 30 days. This is an increase of 17% compared to the previous 30 days.

MarketBeat Follows

Only 4 people have added Stryker to their MarketBeat watchlist in the last 30 days. This is a decrease of -71% compared to the previous 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Stryker insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $75,392,000.00 in company stock.

Percentage Held by Insiders

Only 5.90% of the stock of Stryker is held by insiders.

Percentage Held by Institutions

77.09% of the stock of Stryker is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

SYK Stock Analysis - Frequently Asked Questions

How have SYK shares performed this year?

Stryker's stock was trading at $360.05 on January 1st, 2025. Since then, SYK stock has increased by 8.9% and is now trading at $392.05.

How were Stryker's earnings last quarter?

Stryker Corporation (NYSE:SYK) announced its earnings results on Thursday, May, 1st. The medical technology company reported $2.84 earnings per share for the quarter, beating analysts' consensus estimates of $2.73 by $0.11. The company's revenue was up 11.9% compared to the same quarter last year.
Read the conference call transcript.

Does Stryker have any subsidiaries?

Stryker subsidiaries include these companies: Vocera Communications, Vocera, Gauss Surgical, OrthoSensor, Wright Medical Group, Cardan Robotics, Mobius Imaging, and others.

Who are Stryker's major shareholders?

Top institutional investors of Stryker include Confluence Investment Management LLC (0.06%), Chesley Taft & Associates LLC (0.04%), Czech National Bank (0.02%) and MassMutual Private Wealth & Trust FSB (0.02%). Insiders that own company stock include Ronda E Stryker, Kevin Lobo, James Andrew Pierce, Allan C Golston, M Kathryn Fink, Viju Menon, Robert S Fletcher, Srikant M Datar, William E Berry Jr and Glenn S Boehnlein.
View institutional ownership trends.

How do I buy shares of Stryker?

Shares of SYK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Stryker own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Stryker investors own include Broadcom (AVGO), ServiceNow (NOW), BlackRock (BLK), NVIDIA (NVDA), Meta Platforms (META), UnitedHealth Group (UNH) and Advanced Micro Devices (AMD).

Company Calendar

• Record date for 4/30 Dividend: 3/31/2025
• Ex-Dividend for 4/30 Dividend: 3/31/2025
• Dividend Payable: 4/30/2025
• Last Earnings: 5/01/2025
• Record date for 7/31 Dividend: 6/30/2025
• Ex-Dividend for 7/31 Dividend: 6/30/2025
• Today: 7/09/2025
• Dividend Payable: 7/31/2025
• Next Earnings (Estimated): 7/31/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Health Care Equipment
• Current Symbol: NYSE:SYK
• CIK: 310764
• Web: www.strykercorp.com
• Phone: (269) 385-2600
• Fax: 269-385-1062
• Employees: 53,000
• Year Founded: 1941

Price Target and Rating

• Average Price Target for Stryker: $428.55
• High Price Target: $456.00
• Low Price Target: $370.00
• Potential Upside/Downside: +10.0%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.79
• Research Coverage: 19 Analysts

Profitability

• EPS (Trailing Twelve Months): $7.40
• Trailing P/E Ratio: 52.65
• Forward P/E Ratio: 28.91
• P/E Growth: 2.96
• Net Income: $2.99 billion
• Net Margins: 12.31%
• Pretax Margin: 14.35%
• Return on Equity: 23.74%
• Return on Assets: 11.25%

Debt

• Debt-to-Equity Ratio: 0.69
• Current Ratio: 1.64
• Quick Ratio: 1.00

Sales & Book Value

• Annual Sales: $23.22 billion
• Price / Sales: 6.40
• Cash Flow: $14.97 per share
• Price / Cash Flow: 26.02
• Book Value: $54.13 per share
• Price / Book: 7.19

Miscellaneous

• Outstanding Shares: 381,689,000
• Free Float: 361,841,000
• Market Cap: $148.64 billion
• Optionable: Optionable
• Beta: 0.91